KEEL vs. ARCT

Last updated Jun 9, 2026

KEEL (Keel Infrastructure Corporation) and ARCT (Arcturus Therapeutics Holdings Inc.) are both stocks. KEEL operates in Capital Markets (Financial Services), while ARCT operates in Biotechnology (Healthcare). Over the past 5 years, KEEL returned 5.07%/yr vs -26.90%/yr for ARCT. At a 0.26 correlation, their price movements are largely independent.

Performance

KEEL vs. ARCT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Keel Infrastructure Corporation (KEEL) and Arcturus Therapeutics Holdings Inc. (ARCT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, KEEL achieves a 140.85% return, which is significantly higher than ARCT's 16.15% return.

KEEL

• 1D: 10.33%
• 1M: 42.57%
• YTD: 140.85%
• 6M: 94.50%
• 1Y: 530.92%
• 3Y*: 73.17%
• 5Y*: 5.07%
• 10Y*: —

ARCT

• 1D: -2.47%
• 1M: -22.78%
• YTD: 16.15%
• 6M: -4.43%
• 1Y: -44.33%
• 3Y*: -36.26%
• 5Y*: -26.90%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

KEEL vs. ARCT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
KEEL Keel Infrastructure Corporation	140.85%	57.72%	-48.80%	561.36%	-91.29%	165.79%	471.31%
ARCT Arcturus Therapeutics Holdings Inc.	16.15%	-63.88%	-46.18%	85.91%	-54.17%	-14.68%	155.18%

Correlation

The correlation between KEEL and ARCT is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.22
Correlation (3Y) Calculated over the trailing 3-year period	0.24
Correlation (5Y) Calculated over the trailing 5-year period	0.29
Correlation (All Time) Calculated using the full available price history since Apr 17, 2020	0.26

Fundamentals

Market Cap KEEL : $3.12B ARCT : $202.36M
EPS KEEL : -$0.51 ARCT : -$1.81
PS Ratio KEEL : 13.69 ARCT : 4.19
PB Ratio KEEL : 5.57 ARCT : 1.06
Total Revenue (TTM) KEEL : $229.28M ARCT : $46.80M
Gross Profit (TTM) KEEL : -$18.90M ARCT : $40.72M
EBITDA (TTM) KEEL : -$149.60M ARCT : -$84.61M

Return for Risk

KEEL vs. ARCT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KEEL

KEEL Risk / Return Rank: 95
KEEL Sharpe Ratio Rank: 99
KEEL Sortino Ratio Rank: 95
KEEL Omega Ratio Rank: 93
KEEL Calmar Ratio Rank: 96
KEEL Martin Ratio Rank: 91

ARCT

ARCT Risk / Return Rank: 25
ARCT Sharpe Ratio Rank: 21
ARCT Sortino Ratio Rank: 28
ARCT Omega Ratio Rank: 27
ARCT Calmar Ratio Rank: 21
ARCT Martin Ratio Rank: 26

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KEEL vs. ARCT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Keel Infrastructure Corporation (KEEL) and Arcturus Therapeutics Holdings Inc. (ARCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	KEEL	ARCT	Difference
Sharpe ratio: Return per unit of total volatility	4.85	-0.48	+5.33
Sortino ratio: Return per unit of downside risk	3.97	-0.15	+4.12
Omega ratio: Gain probability vs. loss probability	1.47	0.98	+0.50
Calmar ratio: Return relative to maximum drawdown	7.27	-0.60	+7.87
Martin ratio: Return relative to average drawdown	12.09	-0.83	+12.92
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

KEEL vs. ARCT - Sharpe Ratio Comparison

The current KEEL Sharpe Ratio is 4.85, which is higher than the ARCT Sharpe Ratio of -0.48. The chart below compares the historical Sharpe Ratios of KEEL and ARCT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	KEEL	ARCT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	4.85	-0.48	+5.33
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.05	-0.29	+0.34
Sharpe Ratio (All Time) Calculated using the full available price history	0.07	-0.13	+0.20

Drawdowns

KEEL vs. ARCT - Drawdown Comparison

The maximum KEEL drawdown since its inception was -95.72%, roughly equal to the maximum ARCT drawdown of -95.23%. Use the drawdown chart below to compare losses from any high point for KEEL and ARCT.

Drawdown Indicators

	KEEL	ARCT	Difference
Max Drawdown Largest peak-to-trough decline	-95.72%	-95.23%	-0.49%
Max Drawdown (1Y) Largest decline over 1 year	-73.65%	-74.53%	+0.88%
Max Drawdown (3Y) Largest decline over 3 years	-81.04%	-86.71%	+5.67%
Max Drawdown (5Y) Largest decline over 5 years	-95.72%	-89.87%	-5.85%
Current Drawdown Current decline from peak	-36.19%	-94.24%	+58.05%
Average Drawdown Average peak-to-trough decline	-67.60%	-73.02%	+5.42%
Ulcer Index Depth and duration of drawdowns from previous peaks	44.21%	53.28%	-9.07%

Volatility

KEEL vs. ARCT - Volatility Comparison

Keel Infrastructure Corporation (KEEL) has a higher volatility of 28.39% compared to Arcturus Therapeutics Holdings Inc. (ARCT) at 19.67%. This indicates that KEEL's price experiences larger fluctuations and is considered to be riskier than ARCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	KEEL	ARCT	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.39%	19.67%	+8.72%
Volatility (6M) Calculated over the trailing 6-month period	70.46%	41.10%	+29.36%
Volatility (1Y) Calculated over the trailing 1-year period	110.59%	92.73%	+17.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	105.02%	91.85%	+13.17%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	291.45%	102.23%	+189.22%

Dividends

KEEL vs. ARCT - Dividend Comparison

Neither KEEL nor ARCT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both KEEL and ARCT in my portfolio?

KEEL and ARCT have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, KEEL or ARCT?

KEEL has higher volatility (28.39%) compared to ARCT (19.67%). In terms of maximum drawdown, KEEL dropped -95.72% vs ARCT's -95.23%.

Which has better risk-adjusted returns?

KEEL currently has the higher Sharpe Ratio (4.85 vs -0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.